Berman Capital Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$34K Sell
579
-412
-42% -$25.9K 0.01% 817
2021
Q2
$61K Buy
991
+425
+75% +$28.3K 0.01% 511
2021
Q1
$36K Buy
566
+5
+0.9% +$326 0.01% 598
2020
Q4
$36K Buy
561
+19
+4% +$1.12K 0.01% 496
2020
Q3
$28K Buy
542
+327
+152% +$16.8K 0.01% 491
2020
Q2
$10K Buy
215
+55
+34% +$2.97K ﹤0.01% 754
2020
Q1
$8K Buy
160
+108
+208% +$6.23K ﹤0.01% 719
2019
Q4
$2K Hold
52
﹤0.01% 1191
2019
Q3
$2K Hold
52
﹤0.01% 1170
2019
Q2
$2K Sell
52
-40
-43% -$1.94K ﹤0.01% 1179
2019
Q1
$4K Buy
92
+40
+77% +$2.03K ﹤0.01% 911
2018
Q4
$2K Buy
+52
New +$2.96K ﹤0.01% 856

Other funds holding EHC

Berman Capital Advisors's EHC Position: Q3 2021 in Review

Berman Capital Advisors reduced its Encompass Health (EHC) stake by 42% in Q3 2021, selling an estimated $25.9K and leaving 579 shares worth $34K. The position accounts for 0.01% of the portfolio, ranked #817.

Berman Capital Advisors first reported a position in EHC in Q4 2018 and has held it in 12 quarters since. The position peaked at $61K in Q2 2021. 435 funds tracked by Wall St. Rank hold EHC as of Q3 2021.

  • Berman Capital Advisors held 579 shares of Encompass Health worth $34K as of Q3 2021.
  • Berman Capital Advisors sold 412 Encompass Health shares in Q3 2021, an estimated $25.9K.
  • Encompass Health made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #817 holding.
  • Berman Capital Advisors first reported a position in Encompass Health in Q4 2018 and has held it in 12 quarters since.
  • Berman Capital Advisors's Encompass Health position peaked at $61K in Q2 2021.
  • 435 funds tracked by Wall St. Rank held Encompass Health as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.